Evidence map›Paper›PMID 21093545›Full record

ArticleNeuroscience2011

Early-onset dysfunction of retrosplenial cortex precedes overt amyloid plaque formation in Tg2576 mice.

G L Poirier, E Amin, M A Good, J P Aggleton

Open access · greenAbstract read
In one paragraph

Article in Neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

G L PoirierSchool of Psychology, Cardiff University, 70 Park Place, Cardiff, Wales, CF10 3AT, UK. guillaume.poirier@epfl.ch
E Amin
M A Good
J P Aggleton
Cardiff University · GB

Funding

Medical Research Council G9713086Wellcome Trust 087855
6 · The paper itself

Abstract

A mouse model of amyloid pathology was used to first examine using a cross sectional design changes in retrosplenial cortex activity in transgenic mice aged 5, 11, 17, and 23 months. Attention focused on: (1) overt amyloid labeled with β-amyloid((1-42)) and Congo Red staining, (2) metabolic function assessed by the enzyme, cytochrome oxidase, and (3) neuronal activity as assessed indirectly by the immediate-early gene (IEG), c-Fos. Changes in cytochrome oxidase and c-Fos activity were observed in the retrosplenial cortex in Tg2576 mice as early as 5 months of age, long before evidence of plaque formation. Subsequent analyses concentrating on this early dysfunction revealed at 5 months pervasive, amyloid precursor protein (APP)-derived peptide accumulation in the retrosplenial cortex and selective afferents (anterior thalamus, hippocampus), which was associated with the observed c-Fos hyporeactivity. These findings indicate that retrosplenial cortex dysfunction occurs during early stages of amyloid production in Tg2576 mice and may contribute to cognitive dysfunction.

Indexed as

Amyloid beta-PeptidesAmyloid beta-Protein PrecursorAnimalsElectron Transport Complex IVEntorhinal CortexExploratory BehaviorGyrus CinguliHippocampusMiceMice, TransgenicMutationPeptide FragmentsPlaque, AmyloidProto-Oncogene Proteins c-fosThalamusVisual CortexAmyloid beta-Peptidesamyloid beta-protein (1-42)Amyloid beta-Protein PrecursorElectron Transport Complex IVPeptide FragmentsProto-Oncogene Proteins c-fos

Identifiers

PMID21093545
PMCPMC4235255
OpenAlexW2162593163

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.